![](https://medicaldialogues.in/h-upload/2024/12/13/264722-prostate-cancer-50.jpg)
Low-dose-rate brachytherapy improves recurrence-free survival for recurrent prostate cancer: Study
A new study published in the British Journal of Urology International found that salvage low-dose-rate brachytherapy (LDR-BT) provides a higher recurrence-free survival (RFS) than high-dose-rate brachytherapy (HDR-BT) for radio-recurrent prostate cancer. …